drugset
drugset / Trial / NCT02014142

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

NCT02014142 ↗

Phase 2 Completed 86 enrolled Mati Therapeutics Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Determine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.

Timeline

Start
2013-12
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule — Other

Indications

ocular hypertension open-angle glaucoma